ANNOUNCEMENT

Take a look at the MedCity ENGAGE program, with expert speakers from leading organizations. Reserve your place today.

New broad-spectrum antibiotic based on Nobel Prize-winning research reaches phase 3

New broad-spectrum antibiotic based on Nobel Prize-winning research reaches phase 3

December 4, 2012 3:42 pm by | 0 Comments

Three years ago, Yale University professor of molecular biophysics and biochemistry Thomas Steitz won the Nobel Prize in chemistry for his research on the structure and function of the ribosome. ... Read more

Specialty pharmaceutical maker raising $7.7 million for safer, longer-lasting aspirin

Specialty pharmaceutical maker raising $7.7 million for safer, longer-lasting aspirin

October 15, 2012 11:29 am by | 1 Comments

Reducing the side effects and improving compliance in the millions of people who take aspirin regularly is the goal of a pharmaceutical company raising up to $7.7 million in anticipation ... Read more


Organ retraction tool could reduce abdomen surgery incisions from 3 to 1

Organ retraction tool could reduce abdomen surgery incisions from 3 to 1

June 21, 2012 5:17 pm by | 0 Comments

After raising a $3.2 million series A, a medical device startup that’s developed a tool for minimally invasive gallbladder and appendix removals is eyeing a mid-2013 launch.NovaTract Surgical Inc.’s initial ... Read more

GSK, Yale partner to develop new drugs targeting disease-causing proteins

GSK, Yale partner to develop new drugs targeting disease-causing proteins

May 1, 2012 11:00 am by | 0 Comments

GlaxoSmithKline (NYSE:GSK) hopes to develop a new class of medicines through a new drug discovery partnership with Yale University.The collaboration will build on Yale’s research into ways to break down ... Read more